Literature DB >> 1417129

Remission of scleroderma during chemotherapy for lymphoma.

M Comer1, A R Harvey.   

Abstract

Temporary remission of scleroderma during the successful treatment of an associated malignant lymphoma by chemotherapy is reported in a patient with systemic sclerosis and mixed connective tissue disease. There is a well established relation between malignant disease and polymyositis/dermatomyositis but no overall association with systemic sclerosis or mixed connective tissue disease. Reports of the coexistence of malignancy and systemic sclerosis, however, emphasise a close temporal relation in their occurrence. A review of published work has identified several postulated mechanisms for this relation which may explain the response to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417129      PMCID: PMC1004813          DOI: 10.1136/ard.51.8.998

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

Review 1.  Systemic sclerosis: is there a treatment yet?

Authors:  C M Black
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

2.  Rapidly progressive scleroderma associated with carcinoma of the oesophagus.

Authors:  P C Mattingly; A G Mowat
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

3.  Malignancy in progressive systemic sclerosis--association with breast carcinoma.

Authors:  P Lee; C Alderdice; S Wilkinson; E C Keystone; M B Urowitz; D D Gladman
Journal:  J Rheumatol       Date:  1983-08       Impact factor: 4.666

4.  Suppressor cell loss and dysfunction in mixed connective tissue disease.

Authors:  D Alarcón-Segovia; A Ruíz-Arguelles
Journal:  Arthritis Rheum       Date:  1980-03

5.  Mixed connective tisssue disease: a clinicopathologic study of 20 cases.

Authors:  R M Bennett; D J O'Connell
Journal:  Semin Arthritis Rheum       Date:  1980-08       Impact factor: 5.532

6.  Cancer in connective tissue disease.

Authors:  K A Black; P J Zilko; R L Dawkins; B K Armstrong; G L Mastaglia
Journal:  Arthritis Rheum       Date:  1982-09

Review 7.  Carcinoma of breast and scleroderma: four further cases and a literature review.

Authors:  A M Forbes; J C Woodrow; J L Verbov; R M Graham
Journal:  Br J Rheumatol       Date:  1989-02

8.  Cancer and systemic sclerosis. An epidemiologic study.

Authors:  A D Roumm; T A Medsger
Journal:  Arthritis Rheum       Date:  1985-12

9.  Non-Hodgkin's lymphoma and membranous nephropathy in mixed connective tissue disease.

Authors:  K R McLeish; M R Smith; A F Gohara
Journal:  Am J Med Sci       Date:  1985-10       Impact factor: 2.378

10.  Incidence of lung cancer in systemic sclerosis.

Authors:  M Peters-Golden; R A Wise; M Hochberg; M B Stevens; F M Wigley
Journal:  J Rheumatol       Date:  1985-12       Impact factor: 4.666

View more
  3 in total

Review 1.  Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.

Authors:  Ami A Shah; Antony Rosen
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

2.  Risk of cancer in patients with scleroderma.

Authors:  J E Pearson; A J Silman
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

3.  Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature.

Authors:  M Colaci; D Giuggioli; C Vacchi; C Ferri
Journal:  Case Rep Rheumatol       Date:  2017-05-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.